LICHTENSTEIN K A,ARMON C,BUCHACZ K,et al.Initiation of antiretroviral therapy at CD4 cell counts ≥350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiency[J]. J Acquir Immune Defic Syndr, 2008,47 (1):27-35.
[11]
UY J,ARMON C,BUCHACZ K,et al.Initiation of HAART at higher CD4 cell counts is associated with a lower frequency of antiretroviral drug resistance mutations at virologic failure [J].J Acquir Immune Defic Syndr, 2009,51(4):450-453.
[12]
COHEN M S,CHEN Y Q,MCCAULEY M,et al.Antiretroviral therapy for the prevention of HIV-1 transmission [J]. N Engl J Med, 2016,375(9):830-839.
